How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study. [electronic resource]
Producer: 20060213Description: 7311-21 p. digitalISSN:- 1078-0432
- ADAM Proteins -- genetics
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Hormonal -- therapeutic use
- Breast Neoplasms -- drug therapy
- Female
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
- Matrix Metalloproteinase 2 -- genetics
- Matrix Metalloproteinase 9 -- genetics
- Middle Aged
- Multivariate Analysis
- Neoplasm Recurrence, Local
- Predictive Value of Tests
- Prognosis
- RNA, Messenger -- genetics
- Receptors, Estrogen -- genetics
- Receptors, Progesterone -- genetics
- Retrospective Studies
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Analysis
- Tamoxifen -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.